The Roles of Lpar1 in Central Nervous System Disorders and Diseases

被引:10
|
作者
Xiao, Dongqiong [1 ,2 ]
Su, Xiaojuan [1 ]
Gao, Hu [2 ]
Li, Xihong [2 ]
Qu, Yi [1 ]
机构
[1] Sichuan Univ, West China Univ Hosp 2, Key Lab Birth Defects & Related Dis Women & Child, Dept Pediat,Minist Educ, Chengdu, Peoples R China
[2] Sichuan Univ, West China Second Univ Hosp, Dept Emergency, Minist Educ,Key Lab Birth Defects & Related Dis W, Chengdu, Peoples R China
基金
中国国家自然科学基金;
关键词
Lpar1; Edg2; astroglia; microglia; oligodendrocyte; astrocyte; LYSOPHOSPHATIDIC ACID RECEPTOR; NEURAL STEM-CELLS; LPA(1) RECEPTOR; BLOOD BIOMARKERS; GENE-EXPRESSION; DEFICIENT MICE; ACTIVATION; PROTEIN; BRAIN; OLIGODENDROCYTES;
D O I
10.3389/fnins.2021.710473
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Lysophosphatidic acid receptor 1 (Lpar1), which is found in almost all human tissues but is most abundant in the brain, can couple to G protein-coupled receptors (GPCRs) and participate in regulating cell proliferation, migration, survival, and apoptosis. Endothelial differentiation gene-2 receptor (Edg2), the protein encoded by the Lpar1 gene, is present on various cell types in the central nervous system (CNS), such as neural stem cells (NSCs), oligodendrocytes, neurons, astrocytes, and microglia. Lpar1 deletion causes neurodevelopmental disorders and CNS diseases, such as brain cancer, neuropsychiatric disorders, demyelination diseases, and neuropathic pain. Here, we summarize the possible roles and mechanisms of Lpar1/Edg2 in CNS disorders and diseases and propose that Lpar1/Edg2 might be a potential therapeutic target for CNS disorders and diseases.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Physiological Roles of Metallothioneins in Central Nervous System Diseases
    Nakamura, Shinsuke
    Shimazawa, Masamitsu
    Hara, Hideaki
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2018, 41 (07) : 1006 - 1013
  • [2] ENDOCRINE DISORDERS IN CENTRAL NERVOUS-SYSTEM DISEASES
    FEHM, HL
    VOIGT, KH
    MEDIZINISCHE WELT, 1983, 34 (31-3): : 850 - 855
  • [3] DISORDERS OF ELECTROLYTE METABOLISM IN DISEASES OF THE CENTRAL NERVOUS SYSTEM
    COOPER, IS
    NEUROLOGY, 1953, 3 (02) : 119 - 125
  • [4] The role of LPAR1 and fibrosis in breast cancer metastasis
    Brooks, Danielle L.
    Wakefield, Lalage
    Steeg, Patricia
    CANCER RESEARCH, 2017, 77
  • [5] LPAR1 regulates enteric nervous system function through glial signaling and contributes to chronic intestinal pseudo-obstruction
    Ahmadzai, Mohammad M.
    McClain, Jonathon L.
    Dharshika, Christine
    Seguella, Luisa
    Giancola, Fiorella
    De Giorgio, Roberto
    Gulbransen, Brian D.
    JOURNAL OF CLINICAL INVESTIGATION, 2022, 132 (04):
  • [6] Glymphatic System Dysfunction in Central Nervous System Diseases and Mood Disorders
    Zhang, Dianjun
    Li, Xinyu
    Li, Baoman
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [7] Pathology of nervous regulation in genesis of immune disorders in diseases of central nervous system
    Kryzhanovsky, GN
    Magaeva, SV
    ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 1998, 98 (05): : 60 - 64
  • [8] The Associations Between Central Nervous System Diseases and Haemostatic Disorders
    Podsiedlik, Maria
    Markowicz-Piasecka, Magdalena
    Mikiciuk-Olasik, Elzbieta
    Sikora, Joanna
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2019, 18 (04) : 307 - 316
  • [9] Impact of intestinal disorders on central and peripheral nervous system diseases
    El-Hakim, Yumna
    Bake, Shameena
    Mani, Kathiresh Kumar
    Sohrabji, Farida
    NEUROBIOLOGY OF DISEASE, 2022, 165